Despite their central role in regulation and signalling of GPCRs, a structural understanding of b-arrestin activation and interaction with GPCRs is still lacking. Here we report the crystal structure of b-arrestin-1 (also called arrestin-2) in complex with a fully phosphorylated 29-amino-acid carboxy-terminal peptide derived from the human V2 vasopressin receptor (V2Rpp). This peptide has previously been shown to functionally and conformationally activate b-arrestin-1 (ref. 5). To capture this active conformation, we used a conformationally selective synthetic antibody fragment (Fab30) that recognizes the phosphopeptide-activated state of b-arrestin-1. The structure of the b-arrestin-1-V2Rpp-Fab30 complex shows marked conformational differences in b-arrestin-1 compared to its inactive conformation. These include rotation of the aminoand carboxy-terminal domains relative to each other, and a major reorientation of the 'lariat loop' implicated in maintaining the inactive state of b-arrestin-1. These results reveal, at high resolution, a receptor-interacting interface on b-arrestin, and they indicate a potentially general molecular mechanism for activation of these multifunctional signalling and regulatory proteins.
The functions of G-protein-coupled receptors (GPCRs) are primarily mediated and modulated by three families of proteins: the heterotrimeric G proteins, the G-protein-coupled receptor kinases (GRKs) and the arrestins 1 . G proteins mediate activation of secondmessenger-generating enzymes and other effectors, GRKs phosphorylate activated receptors 2 , and arrestins subsequently bind phosphorylated receptors and cause receptor desensitization 3 . Arrestins activated by interaction with phosphorylated receptors can also mediate G-protein-independent signalling by serving as adaptors to link receptors to numerous signalling pathways 4 . Despite their central role in regulation and signalling of GPCRs, a structural understanding of b-arrestin activation and interaction with GPCRs is still lacking. Here we report the crystal structure of b-arrestin-1 (also called arrestin-2) in complex with a fully phosphorylated 29-amino-acid carboxy-terminal peptide derived from the human V2 vasopressin receptor (V2Rpp). This peptide has previously been shown to functionally and conformationally activate b-arrestin-1 (ref. 5) . To capture this active conformation, we used a conformationally selective synthetic antibody fragment (Fab30) that recognizes the phosphopeptide-activated state of b-arrestin-1. The structure of the b-arrestin-1-V2Rpp-Fab30 complex shows marked conformational differences in b-arrestin-1 compared to its inactive conformation. These include rotation of the aminoand carboxy-terminal domains relative to each other, and a major reorientation of the 'lariat loop' implicated in maintaining the inactive state of b-arrestin-1. These results reveal, at high resolution, a receptor-interacting interface on b-arrestin, and they indicate a potentially general molecular mechanism for activation of these multifunctional signalling and regulatory proteins.
Binding of b-arrestins to phosphorylated GPCRs is thought to involve two types of interaction between a receptor and a b-arrestin molecule 6 . A phosphate sensor engages the phosphorylated carboxy terminus or third intracellular loop of the receptor, and a conformational sensor recognizes the agonist-induced, active conformation of the core of the receptor (Fig. 1a ). Using mass-spectrometry-based conformational mapping, we have previously used a V2 vasopressinreceptor-derived phosphopeptide (V2Rpp) to investigate activation of b-arrestin-1 and b-arrestin-2 (also known as arrestin-3) 5, 7 . Binding to V2Rpp recapitulates functionalities of receptor-activated b-arrestins, such as enhanced clathrin binding 5 . Thus, we reasoned that crystallographic study of a complex of b-arrestin-1 with V2Rpp would provide insight into the mechanisms of receptor-mediated b-arrestin activation. However, well-ordered crystals of b-arrestin-1 bound to V2Rpp could not be obtained. This is presumably due to the significant conformational flexibility of activated arrestin molecules, as was recently determined for visual arrestin (also called arrestin-1) by NMR spectroscopy 8 . Given the success of antigen binding fragments (Fabs) 9 and nanobodies 10 in stabilizing particular GPCR conformations, we sought to identify and characterize conformationally selective Fabs that stabilize the V2Rpp bound, active conformation of b-arrestin-1.
We used a minimalist synthetic Fab phage display library 11 to select several high-affinity Fabs that selectively recognize the b-arrestin-1-V2Rpp complex ( Supplementary Fig. 1 ). One of these, Fab30, displays marked selectivity for the activated conformation of b-arrestin-1 induced by V2Rpp ( Fig. 1b ). To ensure that Fab30 stabilizes a physiologically relevant conformation of b-arrestin-1, we investigated whether this Fab could facilitate interaction between a receptor and b-arrestin-1.
Here, we used the previously described chimaeric receptor b 2 -V2R which has an identical C terminus to V2Rpp, and which also has unaltered ligand-binding characteristics compared to the wild-type b 2 adrenergic receptor (b 2 AR) 12 . Complexes of GPCRs with either G proteins or b-arrestins display an enhanced affinity for agonists due to the allosteric interactions among the agonist, the receptor and the transducer (G protein or b-arrestin) 13, 14 . Addition of exogenous b-arrestin-1 to the membranes containing phosphorylated b 2 -V2R resulted in a small fraction of the receptor in a high-agonist affinity state compared to receptor alone ( Fig. 1c ). Addition of Fab30 significantly increased the percentage of receptors in the high-affinity state. Furthermore, a direct physical stabilization of the receptor-b-arrestin-1 complex by Fab30 was revealed by co-immunoprecipitation ( Fig. 1d ). Here we present a 2.6 Å crystal structure of the b-arrestin-1-V2Rpp-Fab30 complex (Fig. 1e ).
The overall structure of activated b-arrestin-1 exhibits a wide variety of pronounced structural changes compared to previously determined inactive state structures. Most notably, the N and C domains of b-arrestin-1 undergo a substantial twist relative to one another ( Fig. 2a, b) , with a 20u rotation around a central axis. The V2Rpp binds to the N domain at a similar location to the b-arrestin-1 C terminus in inactive structures and makes extensive contacts, primarily through charge-charge interactions of V2Rpp phosphates with b-arrestin-1 arginine and lysine side chains (compare Fig. 2c with Figs 2d and 3d).
This binding mode is consistent with previous limited proteolysis studies that revealed protection of the N domain of b-arrestin-1 in the presence of V2Rpp 5 . Additionally, crosslinking experiments on the b-arrestin-1-V2Rpp complex in the absence of Fab30 show that the N terminus of V2Rpp is in close proximity to K77, consistent with our structure ( Supplementary Fig. 2 ). Like the b-arrestin-1 C terminus, V2Rpp binds b-arrestin-1 by extending the N-domain b-sandwich fold. Unlike the C terminus, however, V2Rpp binds as an antiparallel b-strand. This binding mode may serve as a general mechanism by which arrestins recognize the phosphorylated loops and C-terminal tails of receptors.
In addition to the large interdomain rearrangement, the N domain and central loops show large structural changes associated with b-arrestin-1 activation. Several loops have been implicated in various aspects of b-arrestin activation and receptor interaction 15 . These include the 'finger loop' (residues 63-75), the 'middle loop' (residues 129-140) and the 'lariat loop' (residues 274-300). Each of these loops exhibits activation-dependent conformational changes ( Fig. 2c-e ). Comparison of these loops with inactive structures of b-arrestin-1 shows the considerable flexibility in each loop in the inactive conformation, but a more marked change in conformation upon b-arrestin activation ( Fig. 2e ). The crystal structure reveals that the V2Rpp occludes the inactive conformation of the finger loop, which has been shown to be important for arrestin discrimination between active and inactive GPCRs 16 . V2Rpp may stabilize an extended conformation of this loop to facilitate contact with the receptor core ( Fig. 3a, b ). It is noteworthy that the finger and middle loops above are not at the b-arrestin1-Fab30 interaction interface ( Supplementary Fig. 3 ), and therefore, the conformational reorientation observed for these loops probably reflects activation-dependent changes in b-arrestin-1. However, finger loop residues 63-67 and lariat loop residues 285-287 engage in crystal lattice contacts ( Supplementary Fig. 4 ), so some caution is warranted in the interpretation of conformational changes in these regions.
Two major sets of intramolecular interactions have been proposed to constrain arrestins in an inactive conformation: the three-element interaction and the polar-core interaction. The three-element interaction consists of interactions between b-strand I, a-helix I and the C terminus of arrestin 17 . Disruption of this interaction by mutagenesis yields arrestins that are partially phosphorylation-independent in their binding to receptor 17 , suggesting a key role for this interaction network in recognizing phosphorylated receptors. The crystal structure of b-arrestin-1 shows that two well-conserved residues, K10 and K11 on b-strand I, make charge-charge interactions with phosphorylated residues pS363 and pS357 of V2Rpp (Fig. 3d ). Indeed, mutagenesis of the corresponding lysines in visual arrestin significantly decreases binding to phosphorylated, active rhodopsin, suggesting that these residues serve as essential phosphate recognition elements 17 . Furthermore, previous limited proteolysis studies have indicated that the C terminus of both visual and b-arrestins is released upon activation as part of the disruption of the three-element interaction 5, 18, 19 . Consistent with this model, we observe that the b-arrestin-1 C terminus is displaced by the V2Rpp (Fig. 3c, d) . The b-arrestin-1 C terminus contains a clathrin binding site that has been previously characterized to be important for GPCR internalization 20 . Hence, displacement of the C terminus upon phosphopeptide binding and b-arrestin-1 activation is probably an important contributor to clathrin-mediated GPCR internalization. In comparison to previous models, however, binding of 
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V2Rpp and displacement of the C terminus does not markedly alter the secondary structure of b-strand I. Although we observe abundant charge-charge interactions between b-arrestin-1 and V2Rpp, it is noteworthy that neither the specific sequence of the phosphorylation sites nor the net number of phosphates is conserved among various receptors. Therefore, it remains to be seen how b-arrestins fine-tune their interaction with such a large number of receptors. The second constraint that stabilizes the inactive conformation of arrestins is the polar core 18 , consisting of five interacting charged residues: D26, R169, D290, D297 and R393. Disruption of the polar core by mutagenesis yields phosphorylation-independent mutants of both visual arrestin and b-arrestin-1 (refs 17, 21) . Charge reversal of R169 or D290 in b-arrestin-1 (R175 and D296 in visual arrestin) disrupts this interaction network, yielding arrestins that can bind nonphosphorylated, activated receptors. On the basis of these studies, R169 was previously proposed to be a critical phosphate sensor in b-arrestin-1, and disruption of the polar core was proposed to be required for b-arrestin-1 activation 21 . Contrary to this model, R169 does not make any direct contacts with V2Rpp phosphates, indicating that direct interaction between R169 and receptor phosphates is not required for arrestin activation (Fig. 3e, f) . However, binding of V2Rpp does disrupt the polar core. V2Rpp binding to b-arrestin-1 displaces the arrestin C terminus, and in doing so, removes R393 from the polar core. Residues D290 and D297 also lose interactions within the polar core, and this is accompanied by a marked twisting of the lariat loop, which contains both D290 and D297. Therefore, it is possible that the disruption of the polar core is driven by the excess negative charge in this region following displacement of the arrestin C terminus residue R393. Notably, the side chain of K294, a residue within the lariat loop, flips towards the N domain upon activation and engages pT360. It is possible that K294 recognition of phosphates provides an additional driving force for lariat-loop rearrangement, and may therefore stabilize b-arrestin-1 in an active conformation. This observation in the crystal structure is consistent with crosslinking experiments, which 
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reveal the disappearance of an intrapeptide crosslink between K292 and K294 in the presence of V2Rpp ( Supplementary Fig. 5 ), indicating that V2Rpp induces a conformation like that seen in the crystal structure even in the absence of Fab30. Whereas domain rearrangement upon arrestin activation has been proposed previously, the observed 20u twisting of the N and C domains of b-arrestin-1 upon activation is unanticipated. Biochemical studies have shown that sequential deletion of the visual arrestin hinge region connecting the N and C domains results in a progressive decrease in the ability of arrestin to bind phosphorylated, light-activated rhodopsin. This suggests a requirement for relative movement of the two domains for efficient interaction with activated receptors 22 . However, the twisting motion observed here stands in contrast to the 'clamshell' hypothesis advanced previously 23 . Considering the large number of interaction partners of b-arrestins during cellular signalling 24 , it is tempting to speculate that the twisting movement of the two domains upon arrestin activation may expose interaction interfaces with such binding partners.
Recent NMR and double electron-electron resonance (DEER) studies have assessed the conformational changes induced in visual arrestin upon interaction with phosphorylated, light-activated rhodopsin 8, 25 . Intriguingly, NMR spectroscopy of activated visual arrestin revealed significant line broadening attributed to intermediate timescale conformational dynamics over the entire arrestin molecule 8 . Within such an ensemble of activated arrestin conformations, Fab30 probably stabilizes a conformation of b-arrestin-1 that preferentially binds activated GPCRs. Furthermore, distance restraints for activated visual arrestin derived from DEER experiments are highly consistent with the active structure of b-arrestin-1 presented here ( Supplementary  Fig. 6 ). Most notably, the large conformational change observed for the middle loop by DEER spectroscopy upon binding light-activated, 
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phosphorylated rhodopsin is also evident in the crystal structure of activated b-arrestin-1. Given the importance of this region in maintaining the inactive conformation of visual arrestin, the agreement in conformational changes within arrestin suggests that the V2Rppbound, active conformation of b-arrestin-1 presented here represents a similar state to that of arrestin in complex with a phosphorylated, activated GPCR. This further suggests that the conformational changes associated with activation and receptor binding are conserved throughout the arrestin family. However, the binding stoichiometry between GPCRs and arrestins still remains to be fully established.
Recent biochemical studies have suggested that two rhodopsin molecules may simultaneously bind one arrestin 26 . The extensive and specific contacts between V2Rpp and the b-arrestin-1 N domain probably preclude another receptor C terminus from binding b-arrestin-1. However, it is possible that an arrestin molecule bound to the phosphorylated C terminus of a receptor could interact with the seventransmembrane-segment core of another receptor. Additional data, including a crystal structure of a GPCR-b-arrestin complex, will be required to clarify this. In summary, we present here the structure of an activated arrestin bound to the phosphorylated C terminus of a GPCR. The structure not only provides the atomic details of a potentially general GPCR-barrestin interaction interface, but also offers novel insights into the activation process of arrestins, and reveals a large interdomain twisting associated with activation. These findings will facilitate future efforts to understand the structural basis for b-arrestin activation and signalling. Such studies may ultimately yield insight into how GPCRs achieve such a large breadth of signalling complexity.
METHODS SUMMARY
A truncated version of b-arrestin-1 containing residues 1-393 was expressed in Escherichia coli strain BL21(DE3) and purified to homogeneity using a GST tag and anion exchange chromatography. Fab30 was expressed in E. coli strain 55244 and purified by protein A and cation exchange chromatography. Mixture and incubation of the components yielded the b-arrestin-1-V2Rpp-Fab30 complex, which was purified by size-exclusion chromatography and crystallized using vapour diffusion. Diffraction data were collected at GM/CA-CAT beamline 23ID-D at the Advanced Photon Source at Argonne National Laboratory.
